Other
The Next Frontier of Immuno-Oncology: BOT/BAL
Empowering the immune system to recognize and eliminate cancer—even in tumors that have resisted prior treatments.
What is it about?
BOT + BAL is a combination of two medicines designed to help the body’s immune system fight cancer more effectively. The immune system is the body’s natural defense system. It can find and destroy harmful cells, including cancer cells. However, cancer sometimes finds ways to hide from the immune system or switch it off.
Why is it important?
BOT (botensilimab) helps “wake up” the immune system. It encourages the body to make and activate special immune cells called T cells, which act like soldiers that search for and attack cancer. BOT also helps reduce the activity of certain immune cells that normally slow down immune responses. By lowering these “brakes,” the immune system can respond more strongly. In addition, BOT may help the immune system develop a memory of the cancer, so it can recognize and respond again in the future.
BAL (balstilimab) works in a related but different way. It blocks a signal known as PD-1, which normally acts like a brake pedal on T cells. Cancer cells often use this signal to protect themselves. By blocking PD-1, BAL helps keep T cells active and attacking the cancer.
Together, BOT + BAL aims to help the immune system better recognize cancer, mount a stronger attack, and continue fighting for a longer period of time. This combination is still being studied in clinical trials to better understand how well it works and how safe it is.
This is a demo page.
